Associated factors of vaginal laxity and female sexual function: a cross-sectional study.

female sexual dysfunction pelvic floor disorders pelvic organ prolapse vaginal delivery vaginal laxity

Journal

The journal of sexual medicine
ISSN: 1743-6109
Titre abrégé: J Sex Med
Pays: Netherlands
ID NLM: 101230693

Informations de publication

Date de publication:
13 Apr 2024
Historique:
received: 29 08 2023
revised: 20 01 2024
accepted: 10 02 2024
medline: 14 4 2024
pubmed: 14 4 2024
entrez: 13 4 2024
Statut: aheadofprint

Résumé

Female sexual dysfunction (FSD), including vaginal laxity (VL), can lead to a decrease in quality of life and affect partner relationships. We aimed to investigate the associated factors of VL and FSD and their relationship with other pelvic floor disorders in a female population. This cross-sectional study was conducted at Chelsea and Westminster Hospital from July to December 2022. All women referred to clinical care at the urogynecology clinic were included. Participants were assessed according to sociodemographic and clinical aspects, the Pelvic Organ Prolapse Quantification system, sexual function, VL, sexual attitudes, sexual distress, sexual quality of life, vaginal symptoms, and pelvic floor disorders. Unadjusted and adjusted associated factors of VL and FSD were analyzed. The primary outcome was the identification of the associated factors of VL and FSD in a female population, and secondary outcomes included the association between VL and pelvic organ prolapse (POP) with the questionnaire scores. Among participants (N = 300), vaginal delivery, multiparity, perineal laceration, menopause, and gel hormone were significantly more frequent in those reporting VL (all P < .05). When compared with nulliparity, primiparity and multiparity increased the odds of VL by approximately 4 and 12 times, respectively (unadjusted odds ratio [OR], 4.26 [95% CI, 2.05-8.85]; OR, 12.77 [95% CI, 6.53-24.96]). Menopause and perineal laceration increased the odds of VL by 4 and 6 times (unadjusted OR, 4.65 [95% CI, 2.73-7.93]; OR, 6.13 [95% CI, 3.58-10.49]). In multivariate analysis, menopause, primiparity, multiparity, and POP remained associated with VL. Parity, as an obstetric factor, and menopause and staging of POP, as clinical factors, were associated with VL. The investigation of associated factors for VL will contribute to the understanding of its pathophysiology. The study design makes it impossible to carry out causal inference. Menopause, primiparity, multiparity, and POP were highly associated with VL complaints in multivariate analysis.

Sections du résumé

BACKGROUND BACKGROUND
Female sexual dysfunction (FSD), including vaginal laxity (VL), can lead to a decrease in quality of life and affect partner relationships.
AIM OBJECTIVE
We aimed to investigate the associated factors of VL and FSD and their relationship with other pelvic floor disorders in a female population.
METHODS METHODS
This cross-sectional study was conducted at Chelsea and Westminster Hospital from July to December 2022. All women referred to clinical care at the urogynecology clinic were included. Participants were assessed according to sociodemographic and clinical aspects, the Pelvic Organ Prolapse Quantification system, sexual function, VL, sexual attitudes, sexual distress, sexual quality of life, vaginal symptoms, and pelvic floor disorders. Unadjusted and adjusted associated factors of VL and FSD were analyzed.
OUTCOMES RESULTS
The primary outcome was the identification of the associated factors of VL and FSD in a female population, and secondary outcomes included the association between VL and pelvic organ prolapse (POP) with the questionnaire scores.
RESULTS RESULTS
Among participants (N = 300), vaginal delivery, multiparity, perineal laceration, menopause, and gel hormone were significantly more frequent in those reporting VL (all P < .05). When compared with nulliparity, primiparity and multiparity increased the odds of VL by approximately 4 and 12 times, respectively (unadjusted odds ratio [OR], 4.26 [95% CI, 2.05-8.85]; OR, 12.77 [95% CI, 6.53-24.96]). Menopause and perineal laceration increased the odds of VL by 4 and 6 times (unadjusted OR, 4.65 [95% CI, 2.73-7.93]; OR, 6.13 [95% CI, 3.58-10.49]). In multivariate analysis, menopause, primiparity, multiparity, and POP remained associated with VL.
CLINICAL IMPLICATIONS CONCLUSIONS
Parity, as an obstetric factor, and menopause and staging of POP, as clinical factors, were associated with VL.
STRENGTHS AND LIMITATIONS UNASSIGNED
The investigation of associated factors for VL will contribute to the understanding of its pathophysiology. The study design makes it impossible to carry out causal inference.
CONCLUSION CONCLUSIONS
Menopause, primiparity, multiparity, and POP were highly associated with VL complaints in multivariate analysis.

Identifiants

pubmed: 38614472
pii: 7645313
doi: 10.1093/jsxmed/qdae042
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : São Paulo Research Foundation
ID : 2021/13700-7

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of The International Society of Sexual Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Gláucia Miranda Varella Pereira (GMV)

Department of Obstetrics and Gynaecology, School of Medical Sciences, University of Campinas, Campinas, 13083-881, Brazil.
Department of Metabolism, Digestion and Reproduction, Imperial College London, London, SW7 2AZ, United Kingdom.
Chelsea and Westminster Hospital, London, SW10 9NH, United Kingdom.

Luiz Gustavo Oliveira Brito (LGO)

Department of Obstetrics and Gynaecology, School of Medical Sciences, University of Campinas, Campinas, 13083-881, Brazil.

Nina Ledger (N)

Chelsea and Westminster Hospital, London, SW10 9NH, United Kingdom.

Cássia Raquel Teatin Juliato (CRT)

Department of Obstetrics and Gynaecology, School of Medical Sciences, University of Campinas, Campinas, 13083-881, Brazil.

Claudine Domoney (C)

Chelsea and Westminster Hospital, London, SW10 9NH, United Kingdom.

Rufus Cartwright (R)

Department of Metabolism, Digestion and Reproduction, Imperial College London, London, SW7 2AZ, United Kingdom.
Chelsea and Westminster Hospital, London, SW10 9NH, United Kingdom.
Department of Epidemiology and Biostatistics, Imperial College London, London, SW7 2AZ, UK.

Classifications MeSH